Variant report
Variant | nsv964351 |
---|---|
Chromosome Location | chr2:142837611-142847486 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs113280513 | chr2:142837665-142837666 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs201175445 | chr2:142837668-142837669 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs62702462 | chr2:142837678-142837679 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs557722710 | chr2:142837679-142837680 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs62158863 | chr2:142837682-142837683 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs16848074 | chr2:142837765-142837766 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs552577082 | chr2:142837869-142837870 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs78094578 | chr2:142837873-142837874 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs7609479 | chr2:142837892-142837893 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
10 | rs529045797 | chr2:142837916-142837917 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs183996254 | chr2:142837967-142837968 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs542200420 | chr2:142837984-142837985 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs562478070 | chr2:142837987-142837988 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs531425095 | chr2:142838020-142838021 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs551441140 | chr2:142838025-142838026 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs146722151 | chr2:142838063-142838064 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs188725452 | chr2:142838068-142838069 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs181512527 | chr2:142838081-142838082 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs557528091 | chr2:142838093-142838094 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs186877280 | chr2:142838098-142838099 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs67436974 | chr2:142838099-142838100 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs202159850 | chr2:142838102-142838103 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs78604613 | chr2:142838178-142838179 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs398090725 | chr2:142838179-142838180 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs373651827 | chr2:142838194-142838195 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs546879660 | chr2:142844626-142844627 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs567011314 | chr2:142844688-142844689 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs10179879 | chr2:142844691-142844692 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs549040157 | chr2:142844722-142844723 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs568990289 | chr2:142844723-142844724 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs537887008 | chr2:142844725-142844726 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs558123025 | chr2:142844750-142844751 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs4662373 | chr2:142844780-142844781 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs200805841 | chr2:142844852-142844853 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs140460458 | chr2:142844855-142844856 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs112041271 | chr2:142844856-142844857 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs33939523 | chr2:142844857-142844858 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs35602896 | chr2:142844858-142844859 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs62155560 | chr2:142844859-142844860 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs534047517 | chr2:142844882-142844883 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs35607772 | chr2:142844918-142844919 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs191659678 | chr2:142844929-142844930 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs200968496 | chr2:142844935-142844936 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs370556357 | chr2:142844936-142844937 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs374373420 | chr2:142844937-142844938 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs555480274 | chr2:142844991-142844992 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Mowat-Wilson syndrome | 21572526 | CNVD |
Disorders of sex development | 21048976 | CNVD |
epilepsy | 18472482 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Colorectal cancer | 16272173 | CNVD |
myoclonus epilepsy | 18472482 | CNVD |
Benign familial neonatal-infantile seizures | 18472482 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Prostate cancer | 18632612 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Mental retardation | 22214275 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioblastoma | 21080181 | CNVD |
Cancer | 22183965 | CNVD |
Melanoma | 22183965 | CNVD |
Autism | 22543975 | CNVD |
Cancer | 20164920 | CNVD |
Hypertension | 22686481 | CNVD |
Hypospadia | 22686481 | CNVD |
Intellectual disability | 22686481 | CNVD |
Omphalocele | 22686481 | CNVD |
Prostate cancer | 22341455 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:142829400-142838200 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
2 | chr2:142844600-142845000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |